Though it may start as an isolated tumor of the eye,
becoming a systemic disease.1
As metastatic UM (mUM) runs its course, treatment options are limited and patients face a median survival of up to 12 months.2 So, when you see mUM, think fast.
Presentation and symptoms, risk factors and management
Intrinsic differences between UM and cutaneous melanoma (CM)
Clinical perspectives and resources for patients and caregivers